Trial Profile
A randomized, double-blind, 7-day study of the efficacy and safety of rofecoxib versus placebo and diclofenac in patients with acute painful rotator cuff syndrome
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Rofecoxib (Primary) ; Diclofenac
- Indications Acute pain
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme Corp.
- 08 Jan 2007 Status change
- 10 Nov 2006 New trial record.